“25 mg tablets: white to off-white, oval shaped, film-coated tablets, debossed with "M" and "1" separated breakline on one side and breakline on other side”
M 1 pill
Pill with imprint M 1 is white, oval, 10 mm and has been identified as Metoprolol Succinate 25 mg. It is used for high blood pressure, heart failure and chest pain (angina). It is supplied by Aidarex Pharmaceuticals LLC.
Metoprolol Succinate 25 mg
- Imprint
- M 1
- Strength
- 25 mg
- Used for
- High blood pressure, heart failure and chest pain (angina)
- Color
- White
- Shape
- Oval
- Size
- 10 mm
- Score
- No score line
- Form
- Tablet, extended release
- Manufacturer
- Aidarex Pharmaceuticals LLC
- Drug class
- Beta blocker (heart and blood pressure medicine)
- NDC
- 33261-898, 55111-466, 33261-898-90, 70882-126, 70882-126-30, 70934-113, 70934-113-30, 45865-814, 45865-814-49, 50090-3896, 50090-3896-0, 53002-1781, 53002-1781-3, 53002-1781-0, 71335-0158, 71335-0158-5, 71335-0158-2, 71335-0158-3, 71335-0158-1, 71335-0158-4, 50090-7117, 72603-142, 50090-7117-3, 50090-7117-0, 50090-7117-1, 50090-7118, 50090-7118-0, 43063-624, 43063-624-30, 43063-624-60, 43063-624-90, 55154-7280, 0904-6322, 55154-7280-0, 0615-7823, 0615-7823-39, 0615-7823-05, 0615-7823-30, 0615-7823-28, 55111-466-30
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Metoprolol Succinate used for?
Metoprolol Succinate is used for high blood pressure, heart failure, chest pain (angina) and atrial fibrillation (irregular heartbeat).
- Medicine type
- Beta blocker (heart and blood pressure medicine)
Official uses from the US prescribing label
Hypertension
Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including metoprolol.
Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than 1 drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).
Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.
Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.
Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.
Metoprolol succinate extended-release tablets may be administered with other antihypertensive agents.
Angina Pectoris
Metoprolol succinate extended-release tablets are indicated in the long-term treatment of angina pectoris, to reduce angina attacks and to improve exercise tolerance.
Heart Failure
Metoprolol succinate extended-release tablets are indicated to reduce the risk of cardiovascular mortality and heart-failure hospitalization in patients with heart failure.
From the FDA-approved label on DailyMed (published Sep 18, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- One side shows M 1 and the other side has only a score line.
- It is white, oval, 10 mm.
- The score line, coating and any logo match the photo.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Metoprolol Succinate
Inactive: Acetyltributyl Citrate, Silicon Dioxide, Cellulose, Microcrystalline, Croscarmellose Sodium, Hydroxypropyl Cellulose (Type H), Hypromelloses, Polyethylene Glycol 6000, Sodium Stearyl Fumarate, Talc, Titanium Dioxide, Hydrogenated Cottonseed Oil, Methylene Chloride, Ethylcellulose (10 Mpa.s)
Also distributed by
Cambridge Therapeutics Technologies, LLC, Denton Pharma, Inc. Dba Northwind Pharmaceuticals, Medsource Pharmaceuticals, A-S Medication Solutions, Rpk Pharmaceuticals, Inc., Bryant Ranch Prepack, Pd-Rx Pharmaceuticals, Inc., Cardinal Health 107, LLC, Ncs Healthcare of Ky, LLC Dba Vangard Labs, Dr. Reddy's Laboratories Limited, Quallent Pharmaceuticals Health LLC, Northstar Rx LLC, Avpak, Dr. Reddy's Laboratories Inc, Major Pharmaceuticals, Aphena Pharma Solutions - Tennessee, LLC, American Health Packaging, Redpharm Drug
Other pills with imprint M 1
Same imprint, different listing. Check the color, size and maker against your pill.
- M1 Doxycycline 150 mg Orange, capsule, 6 mm Used for pneumonia and syphilis
- M1 Macitentan 10 mg White, round, 6 mm Used for high blood pressure in the lungs
- M1 Methazolamide 25 mg White, round, 6 mm Used for glaucoma and angle-closure glaucoma
- M 1 Methimazole 5 mg White, round, 6 mm Used for goiter and thyroid crisis
- M1 Milnacipran Hydrochloride 12.5 mg Blue, round, 6 mm Used for major depressive disorder
- M1 Minocycline Hydrochloride 105 mg White, rectangle, 19 mm Used for chest and airway infections and acne
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
CP 295
Ultramicrosize Griseofulvin Tablets 125 mg
White, oval, 11 mm
-
C 3
Clobazam 20 mg
White, oval, 11 mm
Used for seizures
Schedule IV
-
G 304
Norethindrone Acetate 5 mg
White, oval, 11 mm
Used for low testosterone and endometriosis
-
PX 4
Pramipexole Dihydrochloride 1.5 mg
White, oval, 11 mm
Used for depression and Parkinson's disease
-
PX 3
Pramipexole Dihydrochloride 1 mg
White, oval, 11 mm
Used for depression and Parkinson's disease
-
C 2
Clobazam 10 mg
White, oval, 9 mm
Used for seizures
Schedule IV
Other Metoprolol Succinate pills
-
M 3
Metoprolol Succinate 100 mg
White, round, 11 mm
Used for high blood pressure and heart failure
-
M 2
Metoprolol Succinate 50 mg
White, round, 9 mm
Used for high blood pressure and heart failure
- 832 Metoprolol Succinate 100 mg White, round, 10 mm Used for high blood pressure and heart failure
- E283 Metoprolol Succinate 100 mg White, capsule, 14 mm Used for high blood pressure and heart failure
- W 736 Metoprolol Succinate 100 mg White, round, 12 mm Used for high blood pressure and heart failure
- RL16 Metoprolol Succinate 100 mg White, capsule, 18 mm Used for high blood pressure and heart failure
- N 100 Metoprolol Succinate 100 mg White, round, 10 mm Used for high blood pressure and heart failure
- A ms Metoprolol Succinate 100 mg White, round, 10 mm Used for high blood pressure and heart failure